IBS Treatment Market Report

Global and Region IBS Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：197
  • REPORT CODE：GMM901018
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Irritable bowel syndrome (IBS) is a common disorder that affects the digestive system. IBS is characterized by symptoms such as stomach cramps, bloating, diarrhea, and constipation, which impacts one’s everyday life. Although the cause of IBS is unknown, but few factors that cause IBS are severe infection, inflammation in the intestines, muscle contractions in the intestine, changes in bacteria in the gut, and abnormalities in the nerves.

    Rising prevalence of gastrointestinal diseases and disorder, geriatric population, unhealthy diet, anxiety, depression, and changing lifestyle in Americas are the key drivers of the Americas IBS market.

    The report details the trend, potential and market size of IBS Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of IBS Treatmentmarket, defines the market attractiveness level of IBS Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of IBS Treatment industry, describes the types of IBS Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global IBS Treatment market and the development prospects and opportunities of IBS Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global IBS Treatment market in Chapter 13.

    By Player:

    • Abbott Laboratories (US)

    • Takeda Pharmaceutical Company Ltd (Japan)

    • Ironwood Pharmaceuticals, Inc (US)

    • Novartis AG (Switzerland)

    • Synergy Pharmaceuticals, Inc (US)

    • RedHill Biopharma Ltd (Israel)

    • Probi (Sweden)

    • Nestle (Switzerland)

    • Innovate Biopharmaceuticals (US)

    • Allergan Plc (Ireland)

    • Lexicon Pharmaceuticals, Inc (US)

    • Astellas Pharma Inc (Japan)

    • Ipsen (France)

    • Synthetic Biologics, Inc (US)

    • Pfizer Inc (US)

    • Sebela Pharmaceuticals (Ireland)

    • AstraZeneca (UK)

    • Alfasigma USA, Inc (Italy)

    • Sucampo Pharmaceuticals (US)

    • Protagonist Therapeutics Inc (US)

    • Valeant Pharmaceuticals (Canada)

    • Ardelyx, Inc (US)

    By Type:

    • IBS-D

    • IBS-C

    • IBS-M

    By End-User:

    • Hospitals

    • Clinics

    • Research Laboratories

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 IBS Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 IBS Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 IBS Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 IBS Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise IBS Treatment Market Analysis and Outlook to 2022

    • 7.1 Global IBS Treatment Consumption (2017-2022)

    • 7.2 United States IBS Treatment Consumption (2017-2022)

    • 7.3 Europe IBS Treatment Consumption (2017-2022)

    • 7.4 China IBS Treatment Consumption (2017-2022)

    • 7.5 Japan IBS Treatment Consumption (2017-2022)

    • 7.6 India IBS Treatment Consumption (2017-2022)

    • 7.7 South Korea IBS Treatment Consumption (2017-2022)

    8 Region and Country-wise IBS Treatment Market Analysis and Outlook to 2028

    • 8.1 Global IBS Treatment Consumption Forecast (2022-2028)

    • 8.2 United States IBS Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe IBS Treatment Consumption Forecast (2022-2028)

    • 8.4 China IBS Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan IBS Treatment Consumption Forecast (2022-2028)

    • 8.6 India IBS Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea IBS Treatment Consumption Forecast (2022-2028)

    9 Global IBS Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global IBS Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global IBS-D Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global IBS-C Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global IBS-M Consumption and Growth Rate (2017-2022)

    • 9.2 Global IBS Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Research Laboratories Consumption and Growth Rate (2017-2022)

    10 Global IBS Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global IBS Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global IBS-D Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global IBS-C Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global IBS-M Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global IBS Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Research Laboratories Consumption Forecast and Growth Rate (2022-2028)

    11 Global IBS Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global IBS Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global IBS Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 IBS Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global IBS Treatment Market Competitive Analysis

    • 14.1 Abbott Laboratories (US)

      • 14.1.1 Abbott Laboratories (US) Company Details

      • 14.1.2 Abbott Laboratories (US) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Abbott Laboratories (US) IBS Treatment Product and Service

    • 14.2 Takeda Pharmaceutical Company Ltd (Japan)

      • 14.2.1 Takeda Pharmaceutical Company Ltd (Japan) Company Details

      • 14.2.2 Takeda Pharmaceutical Company Ltd (Japan) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Takeda Pharmaceutical Company Ltd (Japan) IBS Treatment Product and Service

    • 14.3 Ironwood Pharmaceuticals, Inc (US)

      • 14.3.1 Ironwood Pharmaceuticals, Inc (US) Company Details

      • 14.3.2 Ironwood Pharmaceuticals, Inc (US) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Ironwood Pharmaceuticals, Inc (US) IBS Treatment Product and Service

    • 14.4 Novartis AG (Switzerland)

      • 14.4.1 Novartis AG (Switzerland) Company Details

      • 14.4.2 Novartis AG (Switzerland) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Novartis AG (Switzerland) IBS Treatment Product and Service

    • 14.5 Synergy Pharmaceuticals, Inc (US)

      • 14.5.1 Synergy Pharmaceuticals, Inc (US) Company Details

      • 14.5.2 Synergy Pharmaceuticals, Inc (US) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Synergy Pharmaceuticals, Inc (US) IBS Treatment Product and Service

    • 14.6 RedHill Biopharma Ltd (Israel)

      • 14.6.1 RedHill Biopharma Ltd (Israel) Company Details

      • 14.6.2 RedHill Biopharma Ltd (Israel) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 RedHill Biopharma Ltd (Israel) IBS Treatment Product and Service

    • 14.7 Probi (Sweden)

      • 14.7.1 Probi (Sweden) Company Details

      • 14.7.2 Probi (Sweden) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Probi (Sweden) IBS Treatment Product and Service

    • 14.8 Nestle (Switzerland)

      • 14.8.1 Nestle (Switzerland) Company Details

      • 14.8.2 Nestle (Switzerland) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Nestle (Switzerland) IBS Treatment Product and Service

    • 14.9 Innovate Biopharmaceuticals (US)

      • 14.9.1 Innovate Biopharmaceuticals (US) Company Details

      • 14.9.2 Innovate Biopharmaceuticals (US) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Innovate Biopharmaceuticals (US) IBS Treatment Product and Service

    • 14.10 Allergan Plc (Ireland)

      • 14.10.1 Allergan Plc (Ireland) Company Details

      • 14.10.2 Allergan Plc (Ireland) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Allergan Plc (Ireland) IBS Treatment Product and Service

    • 14.11 Lexicon Pharmaceuticals, Inc (US)

      • 14.11.1 Lexicon Pharmaceuticals, Inc (US) Company Details

      • 14.11.2 Lexicon Pharmaceuticals, Inc (US) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Lexicon Pharmaceuticals, Inc (US) IBS Treatment Product and Service

    • 14.12 Astellas Pharma Inc (Japan)

      • 14.12.1 Astellas Pharma Inc (Japan) Company Details

      • 14.12.2 Astellas Pharma Inc (Japan) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Astellas Pharma Inc (Japan) IBS Treatment Product and Service

    • 14.13 Ipsen (France)

      • 14.13.1 Ipsen (France) Company Details

      • 14.13.2 Ipsen (France) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Ipsen (France) IBS Treatment Product and Service

    • 14.14 Synthetic Biologics, Inc (US)

      • 14.14.1 Synthetic Biologics, Inc (US) Company Details

      • 14.14.2 Synthetic Biologics, Inc (US) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Synthetic Biologics, Inc (US) IBS Treatment Product and Service

    • 14.15 Pfizer Inc (US)

      • 14.15.1 Pfizer Inc (US) Company Details

      • 14.15.2 Pfizer Inc (US) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Pfizer Inc (US) IBS Treatment Product and Service

    • 14.16 Sebela Pharmaceuticals (Ireland)

      • 14.16.1 Sebela Pharmaceuticals (Ireland) Company Details

      • 14.16.2 Sebela Pharmaceuticals (Ireland) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Sebela Pharmaceuticals (Ireland) IBS Treatment Product and Service

    • 14.17 AstraZeneca (UK)

      • 14.17.1 AstraZeneca (UK) Company Details

      • 14.17.2 AstraZeneca (UK) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 AstraZeneca (UK) IBS Treatment Product and Service

    • 14.18 Alfasigma USA, Inc (Italy)

      • 14.18.1 Alfasigma USA, Inc (Italy) Company Details

      • 14.18.2 Alfasigma USA, Inc (Italy) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Alfasigma USA, Inc (Italy) IBS Treatment Product and Service

    • 14.19 Sucampo Pharmaceuticals (US)

      • 14.19.1 Sucampo Pharmaceuticals (US) Company Details

      • 14.19.2 Sucampo Pharmaceuticals (US) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Sucampo Pharmaceuticals (US) IBS Treatment Product and Service

    • 14.20 Protagonist Therapeutics Inc (US)

      • 14.20.1 Protagonist Therapeutics Inc (US) Company Details

      • 14.20.2 Protagonist Therapeutics Inc (US) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Protagonist Therapeutics Inc (US) IBS Treatment Product and Service

    • 14.21 Valeant Pharmaceuticals (Canada)

      • 14.21.1 Valeant Pharmaceuticals (Canada) Company Details

      • 14.21.2 Valeant Pharmaceuticals (Canada) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.21.3 Valeant Pharmaceuticals (Canada) IBS Treatment Product and Service

    • 14.22 Ardelyx, Inc (US)

      • 14.22.1 Ardelyx, Inc (US) Company Details

      • 14.22.2 Ardelyx, Inc (US) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.22.3 Ardelyx, Inc (US) IBS Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of IBS Treatment

    • Figure IBS Treatment Picture

    • Table Global IBS Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global IBS Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global IBS Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global IBS Treatment Consumption by Country (2017-2022)

    • Figure United States IBS Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe IBS Treatment Consumption and Growth Rate (2017-2022)

    • Figure China IBS Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan IBS Treatment Consumption and Growth Rate (2017-2022)

    • Figure India IBS Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea IBS Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global IBS Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States IBS Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe IBS Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China IBS Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan IBS Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India IBS Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea IBS Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global IBS-D Consumption and Growth Rate (2017-2022)

    • Figure Global IBS-C Consumption and Growth Rate (2017-2022)

    • Figure Global IBS-M Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Research Laboratories Consumption and Growth Rate (2017-2022)

    • Figure Global IBS-D Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global IBS-C Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global IBS-M Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research Laboratories Consumption Forecast and Growth Rate (2022-2028)

    • Table Global IBS Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global IBS Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table Abbott Laboratories (US) (Foundation Year, Company Profile and etc.)

    • Table Abbott Laboratories (US) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories (US) IBS Treatment Product and Service

    • Table Takeda Pharmaceutical Company Ltd (Japan) (Foundation Year, Company Profile and etc.)

    • Table Takeda Pharmaceutical Company Ltd (Japan) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Pharmaceutical Company Ltd (Japan) IBS Treatment Product and Service

    • Table Ironwood Pharmaceuticals, Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Ironwood Pharmaceuticals, Inc (US) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ironwood Pharmaceuticals, Inc (US) IBS Treatment Product and Service

    • Table Novartis AG (Switzerland) (Foundation Year, Company Profile and etc.)

    • Table Novartis AG (Switzerland) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG (Switzerland) IBS Treatment Product and Service

    • Table Synergy Pharmaceuticals, Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Synergy Pharmaceuticals, Inc (US) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Synergy Pharmaceuticals, Inc (US) IBS Treatment Product and Service

    • Table RedHill Biopharma Ltd (Israel) (Foundation Year, Company Profile and etc.)

    • Table RedHill Biopharma Ltd (Israel) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table RedHill Biopharma Ltd (Israel) IBS Treatment Product and Service

    • Table Probi (Sweden) (Foundation Year, Company Profile and etc.)

    • Table Probi (Sweden) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Probi (Sweden) IBS Treatment Product and Service

    • Table Nestle (Switzerland) (Foundation Year, Company Profile and etc.)

    • Table Nestle (Switzerland) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nestle (Switzerland) IBS Treatment Product and Service

    • Table Innovate Biopharmaceuticals (US) (Foundation Year, Company Profile and etc.)

    • Table Innovate Biopharmaceuticals (US) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Innovate Biopharmaceuticals (US) IBS Treatment Product and Service

    • Table Allergan Plc (Ireland) (Foundation Year, Company Profile and etc.)

    • Table Allergan Plc (Ireland) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan Plc (Ireland) IBS Treatment Product and Service

    • Table Lexicon Pharmaceuticals, Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Lexicon Pharmaceuticals, Inc (US) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lexicon Pharmaceuticals, Inc (US) IBS Treatment Product and Service

    • Table Astellas Pharma Inc (Japan) (Foundation Year, Company Profile and etc.)

    • Table Astellas Pharma Inc (Japan) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Inc (Japan) IBS Treatment Product and Service

    • Table Ipsen (France) (Foundation Year, Company Profile and etc.)

    • Table Ipsen (France) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ipsen (France) IBS Treatment Product and Service

    • Table Synthetic Biologics, Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Synthetic Biologics, Inc (US) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Synthetic Biologics, Inc (US) IBS Treatment Product and Service

    • Table Pfizer Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc (US) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc (US) IBS Treatment Product and Service

    • Table Sebela Pharmaceuticals (Ireland) (Foundation Year, Company Profile and etc.)

    • Table Sebela Pharmaceuticals (Ireland) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sebela Pharmaceuticals (Ireland) IBS Treatment Product and Service

    • Table AstraZeneca (UK) (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca (UK) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca (UK) IBS Treatment Product and Service

    • Table Alfasigma USA, Inc (Italy) (Foundation Year, Company Profile and etc.)

    • Table Alfasigma USA, Inc (Italy) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alfasigma USA, Inc (Italy) IBS Treatment Product and Service

    • Table Sucampo Pharmaceuticals (US) (Foundation Year, Company Profile and etc.)

    • Table Sucampo Pharmaceuticals (US) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sucampo Pharmaceuticals (US) IBS Treatment Product and Service

    • Table Protagonist Therapeutics Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Protagonist Therapeutics Inc (US) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Protagonist Therapeutics Inc (US) IBS Treatment Product and Service

    • Table Valeant Pharmaceuticals (Canada) (Foundation Year, Company Profile and etc.)

    • Table Valeant Pharmaceuticals (Canada) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valeant Pharmaceuticals (Canada) IBS Treatment Product and Service

    • Table Ardelyx, Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Ardelyx, Inc (US) IBS Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ardelyx, Inc (US) IBS Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US